Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
106 Leser
Artikel bewerten:
(0)

Global Retinal Surgery Devices Market, 2017-2025: Market was Valued at US$ 1,368.2 Mn in 2016, and is Expected to Reach US$ 2,757.1 Mn by 2025

DUBLIN, Feb. 7, 2018 /PRNewswire/ --

The "Global Retinal Surgery Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global retinal surgery devices market was valued at US$ 1,368.2 Mn in 2016, and is expected to reach US$ 2,757.1 Mn by 2025, expanding at a CAGR of 8.00% from 2017 to 2025.

Market Insights

The global retinal surgery devices market is mainly driven by increasing prevalence of ophthalmic conditions, especially diabetic retinopathy. The prevalence of diabetic retinopathy is witnessing continuous growth due to the increase in diabetic patient pool. Low treatment adherence and compliance to conventional therapeutics on the part of patients has resulted in rise in ophthalmic complications in patients. This event in turn has resulted in growth in the number of retinal surgeries being performed worldwide. Further rise in the pool of high-risk geriatric population has led to addition to the demand for retinal surgery devices. Evolution in reimbursement has also played a critical role in determining the growth trend in the global retinal surgery devices market.

Among the considered device types, vitrectomy packs segment accounts for the largest revenue share in the global retinal surgery devices market. The dominance of this segment is majorly attributed to high usage of viteretomy devices in procedures such as combined retinal surgery, vitreous removal, posterior vitreous detachment, epiretinal membrane removal and others.

Offered advantages such as higher sensitivity, portability and optical magnification also contribute to high demand for vitrectomy packs and are touted to be vital in ophthalmic surgeries. Wide usage of these products thereby will assist in retaining the large revenue share in the global market. Additionally, technological innovation and improved outcome records is expected to make laser systems the fastest growing segment in the global retinal surgery devices market during the forecast period 2017-2025.

Diabetic retinopathy, retinal detachment and macular hole, epiretinal membrane procedure, and ocular injury and infections are the major disease sites where retinal surgery devices find application. Among these, diabetic retinopathy holds the largest share both in terms of revenue generation and number of procedures majorly attributed by continuous rise in prevalence of the disease. The demand for devices such as laser projection equipment, illumination equipment and vitrectomy packs is also the highest in diabetic retinopathy surgeries. Growing awareness among diabetic population through initiatives taken up by manufacturers and governments further drives the progress of this segment.

Geographically, North America is the largest regional market for retinal surgery devices, followed by Europe. Growing base of ophthalmic disease and diabetic population and increasing high demand for minimally invasive surgical procedures mainly drive the market in these regions. Existence of evolved regulatory system and reimbursement scenario additionally boost the growth of retinal surgery devices market in North America and Europe. Additionally, Asia Pacific is estimated to witness the fastest market growth during the forecast period 2017-2025. The growth of Asia Pacific retinal surgery devices market is largely attributed to rapid development of socioeconomic status, growing awareness and evolution of healthcare infrastructure.

Key Topics Covered:

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology

Chapter 2. Executive Summary
2.1. Global Retinal Surgery Devices Market Portraiture
2.1.1. Global Retinal Surgery Devices Market, by Device Type, 2016
2.1.2. Global Retinal Surgery Devices Market, by Disease Site, 2016
2.1.3. Global Retinal Surgery Devices Market, by Geography, 2016

Chapter 3. Retinal Surgery Devices: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography
3.5. Competitive Landscape
3.5.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Retinal Surgery Devices Market, by Device Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.2. Top 3 Countries
4.3. Attractive Investment Proposition, by Device Type
4.4. Vitrectomy Packs
4.5. Vitrectomy Machines
4.6. Microscopic Illumination Equipment
4.7. Retinal Laser Equipment
4.7.1. Photocoagulation Devices
4.7.2. Photodisruption Devices
4.7.3. Selective Laser Trabeculoplasty
4.8. Surgical Instruments (Cannulas, Forceps, Cutters, and Cryoprobes)
4.9. Retinal Tamponade and Sclera Buckles

Chapter 5. Global Retinal Surgery Devices Market, by Disease Site, 2015 - 2025 (US$ Mn)
5.1. Overview
5.2. Top 3 Countries
5.3. Attractive Investment Proposition, by Disease Site
5.4. Diabetic Retinopathy
5.5. Retinal Detachment and Macular Hole
5.6. Epiretinal Membrane Procedure
5.7. Ocular Injury and Infection

Chapter 6. Global Retinal Surgery Devices Market, by Geography, 2015 - 2025

Chapter 7. Company Profiles

  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Ellex Medical Lasers
  • Escalon Medical
  • Erbe Elektromedizin
  • Optos plc
  • IRIDEX Corporation
  • Leica Microsystems GmbH
  • Lumenis
  • Synergetics USA
  • Topcon Corporation

For more information about this report visit https://www.researchandmarkets.com/research/7nv2gd/global_retinal?w=5

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.